{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:36:16Z","timestamp":1780468576090,"version":"3.54.1"},"reference-count":24,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/100010898","name":"Edinburgh and Lothians Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office of the Scottish Government Health and Social Care Directorates","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Heart Diseases Research Fund"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,5,23]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Post hoc analysis of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial of 4146 participants with suspected angina randomised to CTCA. Patients were dichotomised into NICE guideline-defined possible angina and non-anginal presentations. Primary (diagnostic) endpoint was diagnostic certainty of angina at 6 weeks and prognostic endpoint comprised fatal and non-fatal myocardial infarction (MI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In 3770 eligible participants, CTCA increased diagnostic certainty more in those with possible angina (relative risk (RR) 2.22 (95% CI 1.91 to 2.60), p&lt;0.001) than those with non-anginal symptoms (RR 1.30 (1.11 to 1.53), p=0.002; p<jats:sub>interaction<\/jats:sub> &lt;0.001). In the possible angina cohort, CTCA did not change rates of invasive angiography (p=0.481) but markedly reduced rates of normal coronary angiography (HR 0.32 (0.19 to 0.52), p&lt;0.001). In the non-anginal cohort, rates of invasive angiography increased (HR 1.82 (1.13 to 2.92), p=0.014) without reducing rates of normal coronary angiography (HR 0.78 (0.30 to 2.05), p=0.622). At 3.2 years of follow-up, fatal or non-fatal MI was reduced in patients with possible angina (3.2% to 1.9%%; HR 0.58 (0.34 to 0.99), p=0.045) but not in those with non-anginal symptoms (HR 0.65 (0.25 to 1.69), p=0.379).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>NICE-guided patient selection maximises the benefits of CTCA on diagnostic certainty, use of invasive coronary angiography and reductions in fatal and non-fatal myocardial infarction. Patients with non-anginal chest pain derive minimal benefit from CTCA and increase the rates of invasive investigation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ClinicalTrials.gov: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01149590\">NCT01149590<\/jats:ext-link>;post results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2017-311508","type":"journal-article","created":{"date-parts":[[2017,8,27]],"date-time":"2017-08-27T20:10:21Z","timestamp":1503864621000},"page":"207-214","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial"],"prefix":"10.1136","volume":"104","clinical-trial-number":[{"clinical-trial-number":"nct01149590","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Philip D","family":"Adamson","sequence":"first","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Hunter","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C","family":"Williams","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"},{"name":"Edinburgh Imaging, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop S V","family":"Shah","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"McAllister","sequence":"additional","affiliation":[{"name":"Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania A","family":"Pawade","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R","family":"Dweck","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L","family":"Mills","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[{"name":"Institute of Clinical Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A","family":"Boon","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Clark","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Flather","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Forbes","sequence":"additional","affiliation":[{"name":"Health Research Institute, University of Limerick, Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McLean","sequence":"additional","affiliation":[{"name":"National Health Service, Fife, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Roditi","sequence":"additional","affiliation":[{"name":"Institute of Clinical Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J R","family":"van Beek","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"},{"name":"Edinburgh Imaging, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D","family":"Timmis","sequence":"additional","affiliation":[{"name":"William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E","family":"Newby","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,27]]},"reference":[{"key":"2025101714194257000_104.3.207.1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/2249-4863.184625","article-title":"Chest pain in general practice: frequency, management, and results of encounter","volume":"5","author":"Frese","year":"2016","journal-title":"J Family Med Prim Care"},{"key":"2025101714194257000_104.3.207.2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmi124"},{"key":"2025101714194257000_104.3.207.3","doi-asserted-by":"publisher","DOI":"10.3109\/13814780903329528"},{"key":"2025101714194257000_104.3.207.4","unstructured":"National Institute for Health and Clinical Excellence. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. clinical guideline 95. London: NICE 2010."},{"key":"2025101714194257000_104.3.207.5","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdr118"},{"key":"2025101714194257000_104.3.207.6","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcr011"},{"key":"2025101714194257000_104.3.207.7","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2011.118422"},{"key":"2025101714194257000_104.3.207.8","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2012-131098"},{"key":"2025101714194257000_104.3.207.9","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000151"},{"key":"2025101714194257000_104.3.207.10","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.15-3-225"},{"key":"2025101714194257000_104.3.207.11","unstructured":"National Institute for Health and Care Excellence. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin (update). Clinical guideline 95. London: \u00a0NICE, 2016."},{"key":"2025101714194257000_104.3.207.12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-311410"},{"key":"2025101714194257000_104.3.207.13","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-13-184","article-title":"Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, the scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial","volume":"13","author":"Newby","year":"2012","journal-title":"Trials"},{"key":"2025101714194257000_104.3.207.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60291-4"},{"key":"2025101714194257000_104.3.207.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075379","article-title":"Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? evidence from the West of Scotland Coronary Prevention Study","volume":"8","author":"Barry","year":"2013","journal-title":"PLoS One"},{"key":"2025101714194257000_104.3.207.16","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1296"},{"key":"2025101714194257000_104.3.207.17","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg074"},{"key":"2025101714194257000_104.3.207.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1557-4679.1323","article-title":"Relative risk estimation in Randomized Controlled Trials: a comparison of methods for Independent observations","volume":"7","author":"Yelland","year":"2011","journal-title":"Int J Biostat"},{"key":"2025101714194257000_104.3.207.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7450"},{"key":"2025101714194257000_104.3.207.20","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.101715"},{"key":"2025101714194257000_104.3.207.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht296"},{"key":"2025101714194257000_104.3.207.22","doi-asserted-by":"crossref","unstructured":"Fordyce CB , Douglas PS , Roberts RS , et al . Prospective Multicenter Imaging Study for evaluation of chest pain I. identification of patients with stable chest pain deriving minimal value from noninvasive Testing: the PROMISE Minimal-Risk Tool, A secondary analysis of a Randomized clinical trial. JAMA Cardiol 2017.","DOI":"10.1001\/jamacardio.2016.5501"},{"key":"2025101714194257000_104.3.207.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.026"},{"key":"2025101714194257000_104.3.207.24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-311508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:19:48Z","timestamp":1760735988000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-311508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,27]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,1,18]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/heartjnl-2017-311508"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311508","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,27]]}}}